血清基质金属蛋白酶9是检测结直肠癌的有用生物标志物吗？考虑可能影响诊断准确性的分析前干扰因素。 - Suppr

Suppr

超能文献

Is serum matrix metalloproteinase 9 a useful biomarker in detection of colorectal cancer? Considering pre-analytical interference that may influence diagnostic accuracy.

作者信息

Jung K

出版信息

Br J Cancer. 2008 Aug 5;99(3):553-4; author reply 555. doi: 10.1038/sj.bjc.6604491. Epub 2008 Jul 22.

DOI:10.1038/sj.bjc.6604491

PMID:18648367

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2527787/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f7e/2527787/21935f01e2c5/6604491f1.jpg

相似文献

Is serum matrix metalloproteinase 9 a useful biomarker in detection of colorectal cancer? Considering pre-analytical interference that may influence diagnostic accuracy.血清基质金属蛋白酶9是检测结直肠癌的有用生物标志物吗？考虑可能影响诊断准确性的分析前干扰因素。

Br J Cancer. 2008 Aug 5;99(3):553-4; author reply 555. doi: 10.1038/sj.bjc.6604491. Epub 2008 Jul 22.

Serum matrix metalloproteinase-9 level as a biomarker for colorectal cancer: a diagnostic meta-analysis.血清基质金属蛋白酶-9水平作为结直肠癌生物标志物的诊断性Meta分析

Biomark Med. 2018 Apr;12(4):393-402. doi: 10.2217/bmm-2017-0206. Epub 2018 Mar 26.

Elevated serum matrix metalloproteinase 9 concentration predicts the presence of colorectal neoplasia in symptomatic patients.血清基质金属蛋白酶9浓度升高可预测有症状患者结直肠肿瘤的存在。

Br J Cancer. 2008 May 6;98(9):1593; author reply 1594. doi: 10.1038/sj.bjc.6604338. Epub 2008 Apr 15.

Circulating Levels of Matrix Metalloproteinase-9 in Patients with Colorectal Cancer.结直肠癌患者循环中基质金属蛋白酶-9的水平

Scand J Gastroenterol. 2000 Jun;35(6):671-2. doi: 10.1080/003655200750023679.

Serum matrix metalloproteinase-9 in colorectal cancer family-risk population screening.血清基质金属蛋白酶-9在结直肠癌家族风险人群筛查中的应用

Sci Rep. 2015 Aug 12;5:13030. doi: 10.1038/srep13030.

Plasma matrix metalloproteinase 9 as an early surrogate biomarker of advanced colorectal neoplasia.血浆基质金属蛋白酶9作为晚期结直肠肿瘤的早期替代生物标志物。

Gastroenterol Hepatol. 2016 Aug-Sep;39(7):433-41. doi: 10.1016/j.gastrohep.2015.10.002. Epub 2015 Nov 18.

Assessing the value of matrix metalloproteinase 9 (MMP9) in improving the appropriateness of referrals for colorectal cancer.评估基质金属蛋白酶 9（MMP9）在提高结直肠癌转诊适宜性中的价值。

Br J Cancer. 2013 Mar 19;108(5):1149-56. doi: 10.1038/bjc.2013.49. Epub 2013 Feb 7.

A case-control study of pre-operative levels of serum neutrophil gelatinase-associated lipocalin and other potential inflammatory markers in colorectal cancer.一项关于结直肠癌患者术前血清中性粒细胞明胶酶相关脂质运载蛋白及其他潜在炎症标志物水平的病例对照研究。

BMC Cancer. 2014 Dec 3;14:912. doi: 10.1186/1471-2407-14-912.

Serum levels of matrix metalloproteinase-2 and -9 and conventional tumor markers (CEA and CA 19-9) in patients with colorectal and gastric cancers.结直肠癌和胃癌患者血清中基质金属蛋白酶-2和-9以及传统肿瘤标志物（癌胚抗原和糖类抗原19-9）的水平。

Clin Chem Lab Med. 2009;47(8):993-1000. doi: 10.1515/CCLM.2009.212.

High Expression of MMP-9 in Primary Tumors and High Preoperative MPO in Serum Predict Improved Prognosis in Colorectal Cancer with Operable Liver Metastases.原发肿瘤中 MMP-9 的高表达和术前血清中 MPO 的高表达预测可切除肝转移结直肠癌的预后改善。

Oncology. 2021;99(3):144-160. doi: 10.1159/000510609. Epub 2020 Oct 7.

引用本文的文献

Levels of matrix metalloproteinases differ in plasma and serum - aspects regarding analysis of biological markers in cancer.基质金属蛋白酶在血浆和血清中的水平存在差异——癌症生物标志物分析的相关方面。

Br J Cancer. 2016 Sep 6;115(6):703-6. doi: 10.1038/bjc.2016.127. Epub 2016 May 17.

Discovery and validation of new potential biomarkers for early detection of colon cancer.用于结肠癌早期检测的新潜在生物标志物的发现与验证。

PLoS One. 2014 Sep 12;9(9):e106748. doi: 10.1371/journal.pone.0106748. eCollection 2014.

Br J Cancer. 2013 Mar 19;108(5):1149-56. doi: 10.1038/bjc.2013.49. Epub 2013 Feb 7.

The behavior of matrix metalloproteinases and their inhibitors in colorectal cancer.基质金属蛋白酶及其抑制剂在结直肠癌中的行为

Int J Mol Sci. 2012 Oct 16;13(10):13240-63. doi: 10.3390/ijms131013240.

Serum matrix metalloproteinase 9 and colorectal neoplasia: a community-based evaluation of a potential diagnostic test.血清基质金属蛋白酶 9 与结直肠肿瘤：一项基于社区的潜在诊断检测评估。

Br J Cancer. 2012 Apr 10;106(8):1431-8. doi: 10.1038/bjc.2012.93. Epub 2012 Mar 20.

本文引用的文献

Silicate increases the release of MMP-9 forms in peripheral blood: why gelatin zymography differs significantly in citrate plasma and serum obtained with or without clot activators.硅酸盐增加外周血中MMP - 9形式的释放：为什么明胶酶谱法在使用或不使用凝血激活剂获得的枸橼酸盐血浆和血清中有显著差异。

Clin Chem. 2007 Nov;53(11):1981-2. doi: 10.1373/clinchem.2007.090548.

Elevated serum matrix metalloproteinase 9 (MMP-9) concentration predicts the presence of colorectal neoplasia in symptomatic patients.血清基质金属蛋白酶9（MMP-9）浓度升高可预测有症状患者是否存在结直肠肿瘤。

Br J Cancer. 2007 Oct 8;97(7):971-7. doi: 10.1038/sj.bjc.6603958. Epub 2007 Oct 2.

Role of metalloproteinases in platelet function.金属蛋白酶在血小板功能中的作用。

Thromb Res. 2008;121(4):535-42. doi: 10.1016/j.thromres.2007.06.002. Epub 2007 Aug 2.

Plasma matrix metalloproteinase-9 level is better than serum matrix metalloproteinase-9 level to predict gastric cancer evolution.血浆基质金属蛋白酶-9水平在预测胃癌进展方面优于血清基质金属蛋白酶-9水平。

Clin Cancer Res. 2007 Apr 1;13(7):2054-60. doi: 10.1158/1078-0432.CCR-06-2299.

Plasma tissue inhibitor of metalloproteinases-1 as a biological marker? Pre-analytical considerations.血浆金属蛋白酶组织抑制剂-1作为一种生物标志物？分析前的注意事项。

Clin Chim Acta. 2007 May 1;380(1-2):128-32. doi: 10.1016/j.cca.2007.01.022. Epub 2007 Feb 1.

Gelatinase concentrations and zymographic profiles in human breast cancer: matrix metalloproteinases circulating in plasma are better markers for the subclassification and early prediction of cancer: the coagulation/fibrinolysis pathways alter the release, activation and recovery of different gelatinases in serum.人乳腺癌中的明胶酶浓度和酶谱分析：血浆中循环的基质金属蛋白酶是癌症亚分类和早期预测的更好标志物：凝血/纤维蛋白溶解途径会改变血清中不同明胶酶的释放、激活和回收。

Int J Cancer. 2007 Jul 1;121(1):216-8; author reply 219-23. doi: 10.1002/ijc.22652.

Evaluation of the accuracy of serum MMP-9 as a test for colorectal cancer in a primary care population.在基层医疗人群中评估血清基质金属蛋白酶-9作为结直肠癌检测指标的准确性。

BMC Cancer. 2006 Oct 31;6:258. doi: 10.1186/1471-2407-6-258.

A prospective study to assess the value of MMP-9 in improving the appropriateness of urgent referrals for colorectal cancer.一项评估基质金属蛋白酶-9在提高结直肠癌紧急转诊适宜性方面价值的前瞻性研究。

BMC Cancer. 2006 Oct 23;6:251. doi: 10.1186/1471-2407-6-251.

Measurement of matrix metalloproteinases in serum of patients with melanoma: snarled in technical pitfalls.黑色素瘤患者血清中基质金属蛋白酶的测量：陷入技术陷阱。

Clin Cancer Res. 2005 Jul 15;11(14):5069-70. doi: 10.1158/1078-0432.CCR-05-0774.

Matrix metalloproteinase inhibitors as anticancer therapeutics.基质金属蛋白酶抑制剂作为抗癌治疗药物。

Curr Cancer Drug Targets. 2005 Jun;5(4):285-98. doi: 10.2174/1568009054064615.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验